Hepatitis B testing and treatment in HIV patients in The Gambia—Compliance with international guidelines and clinical outcomes
Gibril Ndow(MRC Unit the Gambia), Maud Lemoine(St Mary's Hospital), Yusuke Shimakawa(Institut Pasteur), Mark Thursz(St Mary's Hospital), Coumba Touré‐Kâne(Hôpital Aristide Le Dantec), A. Sow(Hôpital Aristide Le Dantec), Fouzia Sadiq(St Mary's Hospital), Saydiba Tamba(MRC Unit the Gambia), Saihou Sabally, Penda Suso(Edward Francis Small Teaching Hospital), Mindy Gore(Imperial College London), Ramou Njie(MRC Unit the Gambia), Abdoulie Jatta(MRC Unit the Gambia)
Cited by 19
Related Papers
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission
|The Lancet. Gastroenterology & hepatology|2019|539
Association between an MHC Class II Allele and Clearance of Hepatitis B Virus in the Gambia
|New England Journal of Medicine|1995|439
Heterozygote advantage for HLA class-II type in hepatitis B virus infection
|Nature Genetics|1997|319